documents: FDA-2005-N-0345-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2005-N-0345-0002 | FDA | FDA-2005-N-0345 | Distribution of Certain Drug Products by Registered Blood Establishments and Comprehensive Hemophilia Diagnostic Treatment Centers That Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements and Administrative Procedures | Notice | Notice of Final Rule | 2008-10-09T04:00:00Z | 2008 | 10 | 2015-11-04T15:36:44Z | E8-24050 | 0 | 0 | 09000064807410a4 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref